{
    "2018-12-14": [
        [
            {
                "time": "",
                "original_text": "基金调研：215家机构关注华东医药，银华调研当升科技",
                "features": {
                    "keywords": [
                        "基金调研",
                        "华东医药",
                        "银华",
                        "当升科技"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "秦洪看盘｜降低操作频率，静候消息面的积极变化",
                "features": {
                    "keywords": [
                        "秦洪看盘",
                        "降低操作频率",
                        "消息面",
                        "积极变化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药：基层市场销售规模化后，公司整体的销售费用率将会继续下降",
                "features": {
                    "keywords": [
                        "华东医药",
                        "基层市场",
                        "销售费用率",
                        "下降"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:仿制药迎变局，把握确定性投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "仿制药",
                        "变局",
                        "确定性投资机会"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}